The 12th annual Business of Regenerative Medicine conference, hosted by the Harvard Stem Cell Institute on 15-16 July 2019, examined how to define and create “value” in a field set to transform human health.
We are proud to announce that Ya-Chieh Hsu, PhD, has been selected by the Pew Charitable Trust to receive an early-career award that will fund her research for the next four years.
Hsu joined the Harvard Department of Stem Cell and Regenerative Biology (HSCRB) as an assistant professor in 2014, at which time she also became Principal Faculty at the Harvard Stem Cell Institute. Her research is focused on uncovering the function and potential of transit-amplifying skin cells, which play a key role in tissue development, regeneration, and are especially sensitive to chemotherapy drugs. Understanding the role these cells play in skin regeneration could lead to the development of therapies that alleviate or prevent some of the side effects of chemotherapy, such as hair loss and compromised wound healing.
We asked Hsu to share her impressions upon receiving the award.